Moffitt Cancer Center has secured a $22.4 million grant from the U.S. Department of War dedicated to research and clinical trials on leptomeningeal disease, a serious complication from cancer metastasis involving the brain and spinal cord membranes. The funding supports pioneering studies aiming to better understand pathophysiology and develop new treatment approaches against this lethal manifestation, particularly prevalent in breast and other cancers.